Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use MOVANTIK safely and effectively. See full prescribing information for MOVANTIK. MOVANTIK ® (naloxegol) tablets, for oral use Initial U.S. Approval: 2014
Medication labelWhy this: Advisory · dailymed-prescription
MOVANTIK ® is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation.
- generic_name
- naloxegol oxalate
- product_names
- naloxegol oxalate
- ndc
- 82625-8801, 82625-8801-1, 82625-8801-2, 82625-8801-3, 82625-8801-4, 82625-8802, 82625-8802-1, 82625-8802-2, 82625-8802-3, 82625-8802-4
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en